Junhui Sun
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biotechnology top 10%
- Microbial Inactivation Methods
Papers in
- Hepatology 43
- Hepatocellular Carcinoma Treatment and Prognosis 39
- Liver physiology and pathology 3
-
- Microbial Inactivation Methods 5
- Co-authors
- Shusen Zheng (14 shared papers)Guan‐Hui Zhou (15 shared papers)Tong‐Yin Zhu (15 shared papers)Chengjiang Xiao (1 shared paper)Yu Cheng (1 shared paper)Baogang Peng (1 shared paper)Wenzhe Fan (1 shared paper)Fuliang Li (1 shared paper)
- Journals
- Frontiers in Oncology (4 papers)Oncotarget (3 papers)Journal of Hepatology (2 papers)Liver Cancer (2 papers)CardioVascular and Interventional Radiology (2 papers)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Junhui Sun
75 papers receiving 2k citations
Junhui Sun's Hit Papers
Peers
Comparison fields: 5 of 81
- Hepatology 1.2k
- Biotechnology 55
- Genetics 59
- Radiology, Nuclear Medicine and Imaging 142
- Oncology 114
Countries citing papers authored by Junhui Sun
This map shows the geographic impact of Junhui Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Sun more than expected).
Fields of papers citing papers by Junhui Sun
This network shows the impact of papers produced by Junhui Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Sun. The network helps show where Junhui Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhui Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) Hit paper breakdown → | 2022 | 333 |
| 2 | Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) Hit paper breakdown → | 2023 | 212 |
| 3 | 2019 | 206 | |
| 4 | 2018 | 89 | |
| 5 | 2006 | 72 | |
| 6 | 2023 | 71 | |
| 7 | 2015 | 51 | |
| 8 | 2018 | 48 | |
| 9 | 2023 | 45 | |
| 10 | 2022 | 38 | |
| 11 | 2015 | 37 | |
| 12 | 2020 | 36 | |
| 13 | 2022 | 34 | |
| 14 | 2023 | 34 | |
| 15 | 2018 | 33 | |
| 16 | 2020 | 31 | |
| 17 | 2008 | 30 | |
| 18 | 2017 | 30 | |
| 19 | 2009 | 26 | |
| 20 | 2023 | 25 |
About Junhui Sun
Junhui Sun is a scholar working on Hepatology, Biotechnology, Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Mesenchymal stem cell research (6 papers), Microbial Inactivation Methods (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Liver physiology and pathology (3 papers), Characterization and Applications of Magnetic Nanoparticles (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Hepatology (1.2k citations), Biotechnology (55 citations), Genetics (59 citations), Radiology, Nuclear Medicine and Imaging (142 citations) and Oncology (114 citations). Junhui Sun has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Shusen Zheng, Guan‐Hui Zhou, Tong‐Yin Zhu, Chengjiang Xiao, Yu Cheng, Baogang Peng, Wenzhe Fan, Fuliang Li, Guoying Wang and Liangliang Qiao. Their work appears in journals such as Frontiers in Oncology, Oncotarget, Journal of Hepatology, Liver Cancer and CardioVascular and Interventional Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.